Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study

OBJECTIVE: The COVID-19 pandemic has raised questions about the management of systemic immunosuppressive treatments for rheumatic conditions. It is well known that rheumatic patients are at risk of developing infections because of their immunocompromised state. Moreover, drugs such as hydroxychloroq...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarzi-Puttini, Piercarlo, Marotto, Daniela, Caporali, Roberto, Montecucco, Carlo Maurizio, Favalli, Ennio Giulio, Franceschini, Franco, Fredi, Michela, Balduzzi, Silvia, Bazzani, Chiara, Bongiovanni, Sara, Giorgi, Valeria, Batticciotto, Alberto, Cappelli, Antonella, Balzarini, Patrizia, Dagna, Lorenzo, Sartorelli, Silvia, Ravagnani, Viviana, Tamanini, Silvia, Farah, Sonia, Faggioli, Paola, Castelnovo, Laura, Lurati, Alfredo Maria, Galli, Massimo, Salaffi, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506330/
https://www.ncbi.nlm.nih.gov/pubmed/32972804
http://dx.doi.org/10.1016/j.jaut.2020.102545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506330/
https://www.ncbi.nlm.nih.gov/pubmed/32972804
http://dx.doi.org/10.1016/j.jaut.2020.102545

Ejemplares similares